LABORATORY CORP OF AMERICA HOLDINGS Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LABORATORY CORP OF AMERICA HOLDINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LABORATORY CORP OF AMERICA HOLDINGS for February 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 29 2016 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | M | 59.37 | 1,296 | 76,944 | 0 | |
Feb 29 2016 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Sell | S | 109.75 | 1,078 | 118,310 | 29,426 | 30.5 K to 29.4 K (-3.53 %) |
Feb 29 2016 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Sell | S | 109.70 | 218 | 23,915 | 30,504 | 30.7 K to 30.5 K (-0.71 %) |
Feb 29 2016 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Buy | M | 59.37 | 1,296 | 76,944 | 30,722 | 29.4 K to 30.7 K (+4.40 %) |
Feb 18 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Sell | S | 103.02 | 2,160 | 222,523 | 23,454 | 25.6 K to 23.5 K (-8.43 %) |
Feb 18 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Sell | S | 103.02 | 1,895 | 195,223 | 25,614 | 27.5 K to 25.6 K (-6.89 %) |
Feb 18 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Sell | S | 103.02 | 370 | 38,117 | 18,066 | 18.4 K to 18.1 K (-2.01 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Option Exercise | M | 0.00 | 3,334 | 0 | 14,587 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Option Exercise | M | 0.00 | 2,837 | 0 | 17,921 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Option Exercise | M | 0.00 | 4,057 | 0 | 20,758 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Payment of Exercise | F | 103.02 | 1,174 | 120,945 | 27,509 | 28.7 K to 27.5 K (-4.09 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Buy | M | 0.00 | 3,334 | 0 | 28,683 | 25.3 K to 28.7 K (+13.15 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Payment of Exercise | F | 103.02 | 942 | 97,045 | 25,349 | 26.3 K to 25.3 K (-3.58 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Buy | M | 0.00 | 2,837 | 0 | 26,291 | 23.5 K to 26.3 K (+12.10 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Sell | S | 101.67 | 2,712 | 275,729 | 23,454 | 26.2 K to 23.5 K (-10.36 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Payment of Exercise | F | 101.40 | 1,345 | 136,383 | 26,166 | 27.5 K to 26.2 K (-4.89 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Buy | M | 0.00 | 4,057 | 0 | 27,511 | 23.5 K to 27.5 K (+17.30 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 8,270 | 0 | 49,204 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 8,343 | 0 | 57,474 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 103.02 | 3,735 | 384,780 | 91,318 | 95.1 K to 91.3 K (-3.93 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 8,270 | 0 | 95,053 | 86.8 K to 95.1 K (+9.53 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 101.40 | 2,768 | 280,675 | 86,783 | 89.6 K to 86.8 K (-3.09 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 8,343 | 0 | 89,551 | 81.2 K to 89.6 K (+10.27 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 547 | 0 | 3,100 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 550 | 0 | 3,647 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 103.02 | 182 | 18,750 | 7,497 | 7.7 K to 7.5 K (-2.37 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 547 | 0 | 7,679 | 7.1 K to 7.7 K (+7.67 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 101.40 | 212 | 21,497 | 7,132 | 7.3 K to 7.1 K (-2.89 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 550 | 0 | 7,344 | 6.8 K to 7.3 K (+8.10 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,540 | 0 | 29,284 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,673 | 0 | 30,824 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 103.02 | 512 | 52,746 | 6,748 | 7.3 K to 6.7 K (-7.05 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 1,540 | 0 | 7,260 | 5.7 K to 7.3 K (+26.92 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 101.40 | 555 | 56,277 | 5,720 | 6.3 K to 5.7 K (-8.84 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 1,673 | 0 | 6,275 | 4.6 K to 6.3 K (+36.35 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 550 | 0 | 13,170 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 930 | 0 | 13,720 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 101.40 | 179 | 18,151 | 1,938 | 2.1 K to 1.9 K (-8.46 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 550 | 0 | 2,117 | 1.6 K to 2.1 K (+35.10 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 101.40 | 334 | 33,868 | 1,567 | 1.9 K to 1.6 K (-17.57 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 930 | 0 | 1,901 | 971 to 1.9 K (+95.78 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 547 | 0 | 3,584 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 633 | 0 | 4,131 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 103.02 | 177 | 18,235 | 18,436 | 18.6 K to 18.4 K (-0.95 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 547 | 0 | 18,613 | 18.1 K to 18.6 K (+3.03 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Sell | S | 101.67 | 405 | 41,176 | 18,066 | 18.5 K to 18.1 K (-2.19 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 101.40 | 228 | 23,119 | 18,471 | 18.7 K to 18.5 K (-1.22 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 633 | 0 | 18,699 | 18.1 K to 18.7 K (+3.50 %) |
Feb 11 2016 | LH | LABORATORY CORP OF ... | Keller Deborah L | CEO, Covance Drug D ... | Option Exercise | A | 0.00 | 4,120 | 0 | 31,200 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Option Exercise | A | 0.00 | 1,660 | 0 | 24,815 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | A | 0.00 | 1,810 | 0 | 18,780 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | A | 0.00 | 1,350 | 0 | 4,197 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | A | 0.00 | 9,140 | 0 | 32,497 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | A | 0.00 | 5,490 | 0 | 23,357 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 0.00 | 9,140 | 0 | 14,650 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 0.00 | 1,350 | 0 | 5,510 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 22,630 | 0 | 65,817 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | A | 0.00 | 1,560 | 0 | 4,764 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 1,560 | 0 | 2,797 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Option Exercise | A | 0.00 | 1,560 | 0 | 2,797 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Option Exercise | A | 0.00 | 1,560 | 0 | 2,797 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Option Exercise | A | 0.00 | 1,560 | 0 | 2,797 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 0.00 | 1,560 | 0 | 2,797 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Option Exercise | A | 0.00 | 1,560 | 0 | 2,797 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | A | 0.00 | 1,560 | 0 | 2,797 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Option Exercise | A | 0.00 | 1,560 | 0 | 1,560 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | A | 0.00 | 1,560 | 0 | 2,797 |